{"transactions":[{"id":726435,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-25T22:00:03.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":6068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 24, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":6068,"derivative":{"exercise_price":99.87,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":6068},"source":{"system":"sec-edgar","filing":"0001193125-26-283134","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526283134/ownership.xml","form_type":"4"}},{"id":772224,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-19T20:05:06.000Z","date":"2026-05-19","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":9000,"derivative":{"exercise_price":31.2,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-26-230730","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526230730/ownership.xml","form_type":"4"}},{"id":772223,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-19T20:05:06.000Z","date":"2026-05-19","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":31.2,"value":31200.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001193125-26-230730","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526230730/ownership.xml","form_type":"4"}},{"id":832417,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T22:30:04.000Z","date":"2026-03-20","kind":"exercise","planned":true,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":49.1,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001193125-26-118032","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526118032/ownership.xml","form_type":"4"}},{"id":832416,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T22:30:04.000Z","date":"2026-03-20","kind":"sale","planned":true,"acquired":false,"shares":1200,"price":79.9442,"value":95933.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.73 to $80.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-118032","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526118032/ownership.xml","form_type":"4"}},{"id":832415,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T22:30:04.000Z","date":"2026-03-20","kind":"sale","planned":true,"acquired":false,"shares":600,"price":79.2439,"value":47546.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.70 to $79.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1200,"source":{"system":"sec-edgar","filing":"0001193125-26-118032","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526118032/ownership.xml","form_type":"4"}},{"id":832414,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T22:30:04.000Z","date":"2026-03-20","kind":"sale","planned":true,"acquired":false,"shares":700,"price":77.7111,"value":54397.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.46 to $77.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1800,"source":{"system":"sec-edgar","filing":"0001193125-26-118032","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526118032/ownership.xml","form_type":"4"}},{"id":832413,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T22:30:04.000Z","date":"2026-03-20","kind":"exercise","planned":true,"acquired":true,"shares":2500,"price":49.1,"value":122750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001193125-26-118032","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526118032/ownership.xml","form_type":"4"}},{"id":890815,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T22:30:08.000Z","date":"2026-02-20","kind":"exercise","planned":true,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":2500,"derivative":{"exercise_price":49.1,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001193125-26-061686","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526061686/ownership.xml","form_type":"4"}},{"id":890814,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-20T22:30:08.000Z","date":"2026-02-20","kind":"sale","planned":true,"acquired":false,"shares":600,"price":88.1,"value":52860.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.58 to $88.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-061686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526061686/ownership.xml","form_type":"4"}},{"id":890813,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-20T22:30:08.000Z","date":"2026-02-20","kind":"sale","planned":true,"acquired":false,"shares":1900,"price":87.0579,"value":165410.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.52 to $87.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":600,"source":{"system":"sec-edgar","filing":"0001193125-26-061686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526061686/ownership.xml","form_type":"4"}},{"id":890812,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-20T22:30:08.000Z","date":"2026-02-20","kind":"exercise","planned":true,"acquired":true,"shares":2500,"price":49.1,"value":122750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001193125-26-061686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526061686/ownership.xml","form_type":"4"}},{"id":935445,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-20T23:30:24.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":5000,"derivative":{"exercise_price":49.1,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001193125-26-016934","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526016934/ownership.xml","form_type":"4"}},{"id":935444,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-20T23:30:24.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":10000,"derivative":{"exercise_price":31.2,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001193125-26-016934","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526016934/ownership.xml","form_type":"4"}},{"id":935443,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-20T23:30:24.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":200,"price":68.52,"value":13704.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-016934","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526016934/ownership.xml","form_type":"4"}},{"id":935442,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-20T23:30:24.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":4900,"price":67.9888,"value":333145.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.47 to $68.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001193125-26-016934","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526016934/ownership.xml","form_type":"4"}},{"id":935441,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-20T23:30:24.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":400,"price":66.68,"value":26672.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.40 to $66.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5100,"source":{"system":"sec-edgar","filing":"0001193125-26-016934","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526016934/ownership.xml","form_type":"4"}},{"id":935440,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-20T23:30:24.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":true,"shares":2500,"price":49.1,"value":122750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."}],"balance_after":5500,"source":{"system":"sec-edgar","filing":"0001193125-26-016934","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526016934/ownership.xml","form_type":"4"}},{"id":935439,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-20T23:30:24.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":31.2,"value":93600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001193125-26-016934","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526016934/ownership.xml","form_type":"4"}},{"id":965164,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-17T23:07:34.000Z","date":"2025-12-17","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":13000,"derivative":{"exercise_price":31.2,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001193125-25-323090","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525323090/ownership.xml","form_type":"4"}},{"id":965163,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-17T23:07:34.000Z","date":"2025-12-17","kind":"exercise","planned":true,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":27.67,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001193125-25-323090","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525323090/ownership.xml","form_type":"4"}},{"id":965162,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-17T23:07:34.000Z","date":"2025-12-17","kind":"exercise","planned":true,"acquired":false,"shares":12563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":7500,"derivative":{"exercise_price":49.1,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":12563},"source":{"system":"sec-edgar","filing":"0001193125-25-323090","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525323090/ownership.xml","form_type":"4"}},{"id":965161,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T23:07:34.000Z","date":"2025-12-17","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":84.07,"value":84070.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.99 to $84.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-323090","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525323090/ownership.xml","form_type":"4"}},{"id":965160,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T23:07:34.000Z","date":"2025-12-17","kind":"sale","planned":true,"acquired":false,"shares":4099,"price":83.4507,"value":342064.4193,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.99 to $83.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001193125-25-323090","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525323090/ownership.xml","form_type":"4"}},{"id":965159,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T23:07:34.000Z","date":"2025-12-17","kind":"sale","planned":true,"acquired":false,"shares":7959,"price":82.3422,"value":655361.5698,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.99 to $82.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5099,"source":{"system":"sec-edgar","filing":"0001193125-25-323090","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525323090/ownership.xml","form_type":"4"}},{"id":965158,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T23:07:34.000Z","date":"2025-12-17","kind":"sale","planned":true,"acquired":false,"shares":14505,"price":81.557,"value":1182984.285,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.99 to $81.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":13058,"source":{"system":"sec-edgar","filing":"0001193125-25-323090","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525323090/ownership.xml","form_type":"4"}},{"id":965157,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T23:07:34.000Z","date":"2025-12-17","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":31.2,"value":93600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."}],"balance_after":27563,"source":{"system":"sec-edgar","filing":"0001193125-25-323090","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525323090/ownership.xml","form_type":"4"}},{"id":965156,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T23:07:34.000Z","date":"2025-12-17","kind":"exercise","planned":true,"acquired":true,"shares":12000,"price":27.67,"value":332040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."}],"balance_after":24563,"source":{"system":"sec-edgar","filing":"0001193125-25-323090","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525323090/ownership.xml","form_type":"4"}},{"id":965155,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T23:07:34.000Z","date":"2025-12-17","kind":"exercise","planned":true,"acquired":true,"shares":12563,"price":49.1,"value":616843.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person."}],"balance_after":12563,"source":{"system":"sec-edgar","filing":"0001193125-25-323090","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525323090/ownership.xml","form_type":"4"}},{"id":1101117,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-27T01:00:11.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 25, 2026 and (ii) the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":16000,"derivative":{"exercise_price":46.47,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000950170-25-090583","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017025090583/ownership.xml","form_type":"4"}},{"id":1125232,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-03T22:30:08.000Z","date":"2025-06-03","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 18, 2024 adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":24127,"derivative":{"exercise_price":29.55,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-081201","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017025081201/ownership.xml","form_type":"4"}},{"id":1125231,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T22:30:08.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":49.0371,"value":245185.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 18, 2024 adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-081201","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017025081201/ownership.xml","form_type":"4"}},{"id":1125230,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T22:30:08.000Z","date":"2025-06-03","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":29.55,"value":147750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 18, 2024 adopted by the reporting person."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000950170-25-081201","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017025081201/ownership.xml","form_type":"4"}},{"id":1347311,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-03T00:50:40.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 18, 2024 adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":29127,"derivative":{"exercise_price":29.55,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000950170-24-132401","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024132401/ownership.xml","form_type":"4"}},{"id":1347310,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T00:50:40.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":49,"value":122500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 18, 2024 adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-132401","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024132401/ownership.xml","form_type":"4"}},{"id":1347309,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T00:50:40.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":true,"shares":2500,"price":29.55,"value":73875.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 18, 2024 adopted by the reporting person."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0000950170-24-132401","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024132401/ownership.xml","form_type":"4"}},{"id":1405284,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-17T22:20:32.000Z","date":"2024-09-17","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 18, 2024 adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":7000,"derivative":{"exercise_price":14.18,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-24-107458","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024107458/ownership.xml","form_type":"4"}},{"id":1405283,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-17T22:20:32.000Z","date":"2024-09-17","kind":"exercise","planned":true,"acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 18, 2024 adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this stock option are fully vested and exercisable."}],"balance_after":31627,"derivative":{"exercise_price":29.55,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0000950170-24-107458","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024107458/ownership.xml","form_type":"4"}},{"id":1405282,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T22:20:32.000Z","date":"2024-09-17","kind":"sale","planned":true,"acquired":false,"shares":7150,"price":48.7526,"value":348581.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 18, 2024 adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.26 to $49.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-107458","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024107458/ownership.xml","form_type":"4"}},{"id":1405281,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T22:20:32.000Z","date":"2024-09-17","kind":"sale","planned":true,"acquired":false,"shares":6350,"price":47.7456,"value":303184.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 18, 2024 adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.26 to $48.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7150,"source":{"system":"sec-edgar","filing":"0000950170-24-107458","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024107458/ownership.xml","form_type":"4"}},{"id":1405280,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T22:20:32.000Z","date":"2024-09-17","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":14.18,"value":70900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 18, 2024 adopted by the reporting person."}],"balance_after":13500,"source":{"system":"sec-edgar","filing":"0000950170-24-107458","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024107458/ownership.xml","form_type":"4"}},{"id":1405279,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T22:20:32.000Z","date":"2024-09-17","kind":"exercise","planned":true,"acquired":true,"shares":8500,"price":29.55,"value":251175.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 18, 2024 adopted by the reporting person."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0000950170-24-107458","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024107458/ownership.xml","form_type":"4"}},{"id":1473321,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T21:00:17.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 18, 2025 and (ii) the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":16000,"derivative":{"exercise_price":31.2,"expiration_date":"2034-06-17","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000950170-24-075705","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024075705/ownership.xml","form_type":"4"}},{"id":1781712,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-09-14T01:02:56.000Z","date":"2023-09-12","kind":"exercise","planned":true,"acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted an option to purchase 134,281 shares of the Issuer's common stock on July 26, 2017. All of the shares underlying such stock option have vested and are exercisable as of the date hereof."}],"balance_after":86033,"derivative":{"exercise_price":3.3,"expiration_date":"2027-07-26","underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001104659-23-100560","document":"tm2325969-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923100560/tm2325969-1_4seq1.xml","form_type":"4"}},{"id":1781711,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-09-14T01:02:56.000Z","date":"2023-09-11","kind":"exercise","planned":true,"acquired":false,"shares":5358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted an option to purchase 134,281 shares of the Issuer's common stock on July 26, 2017. All of the shares underlying such stock option have vested and are exercisable as of the date hereof."}],"balance_after":86333,"derivative":{"exercise_price":3.3,"expiration_date":"2027-07-26","underlying":"Common Stock","underlying_shares":5358},"source":{"system":"sec-edgar","filing":"0001104659-23-100560","document":"tm2325969-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923100560/tm2325969-1_4seq1.xml","form_type":"4"}},{"id":1781710,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-09-14T01:02:56.000Z","date":"2023-09-12","kind":"sale","planned":true,"acquired":false,"shares":300,"price":20,"value":6000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 15, 2023, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 263,436 shares of the Issuer's common stock, including restricted stock units. The reporting person also holds options to acquire an aggregate of 491,569 shares of the Issuer's common stock, 376,774 of which are exercisable as of the date hereof."}],"balance_after":263436,"source":{"system":"sec-edgar","filing":"0001104659-23-100560","document":"tm2325969-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923100560/tm2325969-1_4seq1.xml","form_type":"4"}},{"id":1781709,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-09-14T01:02:56.000Z","date":"2023-09-12","kind":"exercise","planned":true,"acquired":true,"shares":300,"price":3.3,"value":990.0,"ownership":{"direct":true},"balance_after":263736,"source":{"system":"sec-edgar","filing":"0001104659-23-100560","document":"tm2325969-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923100560/tm2325969-1_4seq1.xml","form_type":"4"}},{"id":1781708,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-09-14T01:02:56.000Z","date":"2023-09-11","kind":"sale","planned":true,"acquired":false,"shares":5358,"price":20.01,"value":107213.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 15, 2023, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.05. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":263436,"source":{"system":"sec-edgar","filing":"0001104659-23-100560","document":"tm2325969-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923100560/tm2325969-1_4seq1.xml","form_type":"4"}},{"id":1781707,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-09-14T01:02:56.000Z","date":"2023-09-11","kind":"exercise","planned":true,"acquired":true,"shares":5358,"price":3.3,"value":17681.4,"ownership":{"direct":true},"balance_after":268794,"source":{"system":"sec-edgar","filing":"0001104659-23-100560","document":"tm2325969-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923100560/tm2325969-1_4seq1.xml","form_type":"4"}},{"id":1797370,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-08-25T00:30:30.000Z","date":"2023-08-22","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted an option to purchase 75,750 shares of the Issuer's common stock on April 1, 2019. All of the shares underlying such stock option have vested and are exercisable as of the date hereof."}],"balance_after":35750,"derivative":{"exercise_price":15.5,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-23-094997","document":"tm2324763-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923094997/tm2324763-1_4seq1.xml","form_type":"4"}},{"id":1797369,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-08-25T00:30:30.000Z","date":"2023-08-22","kind":"exercise","planned":true,"acquired":false,"shares":13600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted an option to purchase 134,281 shares of the Issuer's common stock on July 26, 2017. All of the shares underlying such stock option have vested and are exercisable as of the date hereof."}],"balance_after":91691,"derivative":{"exercise_price":3.3,"expiration_date":"2027-07-26","underlying":"Common Stock","underlying_shares":13600},"source":{"system":"sec-edgar","filing":"0001104659-23-094997","document":"tm2324763-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923094997/tm2324763-1_4seq1.xml","form_type":"4"}},{"id":1797368,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-08-25T00:30:30.000Z","date":"2023-08-22","kind":"sale","planned":true,"acquired":false,"shares":18600,"price":20.01,"value":372186.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 15, 2023, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.04. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 263,436 shares of the Issuer's common stock, including restricted stock units. The reporting person also holds options to acquire an aggregate of 497,227 shares of the Issuer's common stock, 378,873 of which are exercisable as of the date hereof."}],"balance_after":263436,"source":{"system":"sec-edgar","filing":"0001104659-23-094997","document":"tm2324763-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923094997/tm2324763-1_4seq1.xml","form_type":"4"}},{"id":1797367,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-08-25T00:30:30.000Z","date":"2023-08-22","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":15.5,"value":77500.0,"ownership":{"direct":true},"balance_after":282036,"source":{"system":"sec-edgar","filing":"0001104659-23-094997","document":"tm2324763-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923094997/tm2324763-1_4seq1.xml","form_type":"4"}},{"id":1797366,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-08-25T00:30:30.000Z","date":"2023-08-22","kind":"exercise","planned":true,"acquired":true,"shares":13600,"price":3.3,"value":44880.0,"ownership":{"direct":true},"balance_after":277036,"source":{"system":"sec-edgar","filing":"0001104659-23-094997","document":"tm2324763-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923094997/tm2324763-1_4seq1.xml","form_type":"4"}},{"id":1806983,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-08-16T00:30:10.000Z","date":"2023-08-11","kind":"exercise","planned":true,"acquired":false,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted an option to purchase 134,281 shares of the Issuer's common stock on July 26, 2017. All of the shares underlying such stock option have vested and are exercisable as of the date hereof."}],"balance_after":105291,"derivative":{"exercise_price":3.3,"expiration_date":"2027-07-26","underlying":"Common Stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001104659-23-092111","document":"tm2323841-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923092111/tm2323841-1_4seq1.xml","form_type":"4"}},{"id":1806982,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-08-16T00:30:10.000Z","date":"2023-08-11","kind":"sale","planned":true,"acquired":false,"shares":1400,"price":20,"value":28000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 15, 2023, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 263,436 shares of the Issuer's common stock, including restricted stock units. The reporting person also holds options to acquire an aggregate of 515,827 shares of the Issuer's common stock, 397,473 of which are exercisable as of the date hereof."}],"balance_after":263436,"source":{"system":"sec-edgar","filing":"0001104659-23-092111","document":"tm2323841-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923092111/tm2323841-1_4seq1.xml","form_type":"4"}},{"id":1806981,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-08-16T00:30:10.000Z","date":"2023-08-11","kind":"exercise","planned":true,"acquired":true,"shares":1400,"price":3.3,"value":4620.0,"ownership":{"direct":true},"balance_after":264836,"source":{"system":"sec-edgar","filing":"0001104659-23-092111","document":"tm2323841-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923092111/tm2323841-1_4seq1.xml","form_type":"4"}},{"id":1831418,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-07-12T01:00:14.000Z","date":"2023-07-10","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The reporting person was granted an option to purchase 75,750 shares of the Issuer's common stock on April 1, 2019. All of the shares underlying such stock option have vested and are exercisable as of the date hereof."}],"balance_after":40750,"derivative":{"exercise_price":15.5,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-23-080113","document":"tm2321083-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923080113/tm2321083-1_4seq1.xml","form_type":"4"}},{"id":1831417,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-07-12T01:00:14.000Z","date":"2023-07-10","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted an option to purchase 134,281 shares of the Issuer's common stock on July 26, 2017. All of the shares underlying such stock option have vested and are exercisable as of the date hereof."}],"balance_after":106691,"derivative":{"exercise_price":3.3,"expiration_date":"2027-07-26","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-23-080113","document":"tm2321083-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923080113/tm2321083-1_4seq1.xml","form_type":"4"}},{"id":1831416,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-07-12T01:00:14.000Z","date":"2023-07-10","kind":"sale","planned":true,"acquired":false,"shares":2077,"price":21.12,"value":43866.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 15, 2023, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.09 to $21.17. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 263,436 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 517,227 shares of the Issuer's common stock, 395,314 of which are exercisable as of the date hereof."}],"balance_after":263436,"source":{"system":"sec-edgar","filing":"0001104659-23-080113","document":"tm2321083-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923080113/tm2321083-1_4seq1.xml","form_type":"4"}},{"id":1831415,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-07-12T01:00:14.000Z","date":"2023-07-10","kind":"sale","planned":true,"acquired":false,"shares":17923,"price":21.63,"value":387674.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 15, 2023, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.18 to $22.17. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":265513,"source":{"system":"sec-edgar","filing":"0001104659-23-080113","document":"tm2321083-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923080113/tm2321083-1_4seq1.xml","form_type":"4"}},{"id":1831414,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-07-12T01:00:14.000Z","date":"2023-07-10","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":15.5,"value":77500.0,"ownership":{"direct":true},"balance_after":283436,"source":{"system":"sec-edgar","filing":"0001104659-23-080113","document":"tm2321083-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923080113/tm2321083-1_4seq1.xml","form_type":"4"}},{"id":1831413,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-07-12T01:00:14.000Z","date":"2023-07-10","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":3.3,"value":49500.0,"ownership":{"direct":true},"balance_after":278436,"source":{"system":"sec-edgar","filing":"0001104659-23-080113","document":"tm2321083-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923080113/tm2321083-1_4seq1.xml","form_type":"4"}},{"id":1849729,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-20T20:15:14.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 15, 2024 and (ii) the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":12000,"derivative":{"exercise_price":27.67,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-23-015961","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000089924323015961/doc4.xml","form_type":"4"}},{"id":1886405,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-05-19T00:31:06.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":5966,"price":18.05,"value":107686.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units (\"RSU\"). The transaction reported herein was made in accordance with the irrevocable \"sell to cover\" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.05 to $18.32. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":263436,"source":{"system":"sec-edgar","filing":"0001104659-23-062372","document":"tm2316199-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923062372/tm2316199-3_4seq1.xml","form_type":"4"}},{"id":1926595,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-05T00:02:29.000Z","date":"2023-04-01","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on April 1, 2024, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":60000,"derivative":{"exercise_price":17.66,"expiration_date":"2033-04-01","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-23-041727","document":"tm2311410-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923041727/tm2311410-8_4seq1.xml","form_type":"4"}},{"id":1926594,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-04-05T00:02:29.000Z","date":"2023-04-01","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2024 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2027, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":269402,"source":{"system":"sec-edgar","filing":"0001104659-23-041727","document":"tm2311410-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923041727/tm2311410-8_4seq1.xml","form_type":"4"}},{"id":2087413,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-14T01:01:12.000Z","date":"2022-12-09","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof."}],"balance_after":36203,"derivative":{"exercise_price":1.01,"expiration_date":"2025-11-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-22-126741","document":"tm2232604-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465922126741/tm2232604-1_4seq1.xml","form_type":"4"}},{"id":2087412,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2022-12-14T01:01:12.000Z","date":"2022-12-09","kind":"sale","acquired":false,"shares":15000,"price":25.03,"value":375450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 13, 2021, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $25 to $25.14. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 229,402 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 477,227 shares of the Issuer's common stock,  378,400 of which are exercisable as of the date hereof."}],"balance_after":229402,"source":{"system":"sec-edgar","filing":"0001104659-22-126741","document":"tm2232604-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465922126741/tm2232604-1_4seq1.xml","form_type":"4"}},{"id":2087411,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2022-12-14T01:01:12.000Z","date":"2022-12-09","kind":"exercise","acquired":true,"shares":15000,"price":1.01,"value":15150.0,"ownership":{"direct":true},"balance_after":244402,"source":{"system":"sec-edgar","filing":"0001104659-22-126741","document":"tm2232604-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465922126741/tm2232604-1_4seq1.xml","form_type":"4"}},{"id":2230127,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T20:06:00.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 15, 2023 and (ii) the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":12000,"derivative":{"exercise_price":14.18,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-22-022795","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000089924322022795/doc4.xml","form_type":"4"}},{"id":2265124,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2022-05-18T23:03:44.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":3507,"price":14.59,"value":51167.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units (\"RSU\"). The transaction reported herein was made in accordance with the irrevocable \"sell to cover\" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person."}],"balance_after":229402,"source":{"system":"sec-edgar","filing":"0001104659-22-062610","document":"tm2215879-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465922062610/tm2215879-7_4seq1.xml","form_type":"4"}},{"id":2303344,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-05T20:15:18.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":34125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on April 1, 2023, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":34125,"derivative":{"exercise_price":18.26,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":34125},"source":{"system":"sec-edgar","filing":"0001104659-22-042762","document":"tm2211665-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465922042762/tm2211665-6_4seq1.xml","form_type":"4"}},{"id":2303343,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2022-04-05T20:15:18.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":22750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2023 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2026, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":232909,"source":{"system":"sec-edgar","filing":"0001104659-22-042762","document":"tm2211665-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465922042762/tm2211665-6_4seq1.xml","form_type":"4"}},{"id":2611078,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-07T01:01:02.000Z","date":"2021-08-05","kind":"exercise","acquired":false,"shares":25800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares underlying this stock option vested on April 1, 2020, and the remainder of the shares underlying this stock option vested or will vest, as applicable, in 36 approximately equal monthly installments thereafter."}],"balance_after":45750,"derivative":{"exercise_price":15.5,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":25800},"source":{"system":"sec-edgar","filing":"0001104659-21-101719","document":"tm2124335-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921101719/tm2124335-1_4seq1.xml","form_type":"4"}},{"id":2611077,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-07T01:01:02.000Z","date":"2021-08-04","kind":"exercise","acquired":false,"shares":4200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares underlying this stock option vested on April 1, 2020, and the remainder of the shares underlying this stock option vested or will vest, as applicable, in 36 approximately equal monthly installments thereafter."}],"balance_after":71550,"derivative":{"exercise_price":15.5,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":4200},"source":{"system":"sec-edgar","filing":"0001104659-21-101719","document":"tm2124335-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921101719/tm2124335-1_4seq1.xml","form_type":"4"}},{"id":2611076,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-08-07T01:01:02.000Z","date":"2021-08-05","kind":"sale","acquired":false,"shares":25800,"price":35.09,"value":905322.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $35 to $35.38. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 210,159 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 458,102 shares of the Issuer's common stock, 300,811 of which are exercisable as of the date hereof."}],"balance_after":210159,"source":{"system":"sec-edgar","filing":"0001104659-21-101719","document":"tm2124335-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921101719/tm2124335-1_4seq1.xml","form_type":"4"}},{"id":2611075,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-08-07T01:01:02.000Z","date":"2021-08-05","kind":"exercise","acquired":true,"shares":25800,"price":15.5,"value":399900.0,"ownership":{"direct":true},"balance_after":235959,"source":{"system":"sec-edgar","filing":"0001104659-21-101719","document":"tm2124335-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921101719/tm2124335-1_4seq1.xml","form_type":"4"}},{"id":2611074,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-08-07T01:01:02.000Z","date":"2021-08-04","kind":"sale","acquired":false,"shares":4200,"price":35,"value":147000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $35 to $35.05. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":210159,"source":{"system":"sec-edgar","filing":"0001104659-21-101719","document":"tm2124335-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921101719/tm2124335-1_4seq1.xml","form_type":"4"}},{"id":2611073,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-08-07T01:01:02.000Z","date":"2021-08-04","kind":"exercise","acquired":true,"shares":4200,"price":15.5,"value":65100.0,"ownership":{"direct":true},"balance_after":214359,"source":{"system":"sec-edgar","filing":"0001104659-21-101719","document":"tm2124335-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921101719/tm2124335-1_4seq1.xml","form_type":"4"}},{"id":2626846,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-07-23T01:01:05.000Z","date":"2021-07-21","kind":"exercise","acquired":false,"shares":12538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof."}],"balance_after":51203,"derivative":{"exercise_price":1.01,"expiration_date":"2025-11-01","underlying":"Common Stock","underlying_shares":12538},"source":{"system":"sec-edgar","filing":"0001104659-21-095084","document":"tm2123078-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921095084/tm2123078-1_4seq1.xml","form_type":"4"}},{"id":2626845,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-07-23T01:01:05.000Z","date":"2021-07-20","kind":"exercise","acquired":false,"shares":4862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof."}],"balance_after":63741,"derivative":{"exercise_price":1.01,"expiration_date":"2025-11-01","underlying":"Common Stock","underlying_shares":4862},"source":{"system":"sec-edgar","filing":"0001104659-21-095084","document":"tm2123078-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921095084/tm2123078-1_4seq1.xml","form_type":"4"}},{"id":2626844,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-07-23T01:01:05.000Z","date":"2021-07-21","kind":"sale","acquired":false,"shares":12538,"price":33.17,"value":415885.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 210,159 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 488,102 shares of the Issuer's common stock, 324,649 of which are exercisable as of the date hereof. Due to scrivener's error, footnote 2 of the Form 4 filed on behalf of the reporting person on July 19, 2021 inadvertently overstated the number of options held by the Reporting Person following the transaction reported therein. The amounts stated in this footnote 2 set forth the correct number of options held by the Reporting Person following the transaction reported herein."}],"balance_after":210159,"source":{"system":"sec-edgar","filing":"0001104659-21-095084","document":"tm2123078-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921095084/tm2123078-1_4seq1.xml","form_type":"4"}},{"id":2626843,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-07-23T01:01:05.000Z","date":"2021-07-21","kind":"exercise","acquired":true,"shares":12538,"price":1.01,"value":12663.38,"ownership":{"direct":true},"balance_after":222697,"source":{"system":"sec-edgar","filing":"0001104659-21-095084","document":"tm2123078-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921095084/tm2123078-1_4seq1.xml","form_type":"4"}},{"id":2626842,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-07-23T01:01:05.000Z","date":"2021-07-20","kind":"sale","acquired":false,"shares":4862,"price":33.05,"value":160689.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."}],"balance_after":210159,"source":{"system":"sec-edgar","filing":"0001104659-21-095084","document":"tm2123078-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921095084/tm2123078-1_4seq1.xml","form_type":"4"}},{"id":2626841,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-07-23T01:01:05.000Z","date":"2021-07-20","kind":"exercise","acquired":true,"shares":4862,"price":1.01,"value":4910.62,"ownership":{"direct":true},"balance_after":215021,"source":{"system":"sec-edgar","filing":"0001104659-21-095084","document":"tm2123078-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921095084/tm2123078-1_4seq1.xml","form_type":"4"}},{"id":2629942,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-07-20T01:02:56.000Z","date":"2021-07-15","kind":"exercise","acquired":false,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof."}],"balance_after":68603,"derivative":{"exercise_price":1.01,"expiration_date":"2025-11-01","underlying":"Common Stock","underlying_shares":4600},"source":{"system":"sec-edgar","filing":"0001104659-21-093671","document":"tm2122438-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921093671/tm2122438-2_4seq1.xml","form_type":"4"}},{"id":2629941,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-07-20T01:02:56.000Z","date":"2021-07-15","kind":"sale","acquired":false,"shares":4600,"price":33.37,"value":153502.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 210,159 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 544,267 shares of the Issuer's common stock, 345,191 of which are exercisable as of the date hereof."}],"balance_after":210159,"source":{"system":"sec-edgar","filing":"0001104659-21-093671","document":"tm2122438-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921093671/tm2122438-2_4seq1.xml","form_type":"4"}},{"id":2629940,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-07-20T01:02:56.000Z","date":"2021-07-15","kind":"exercise","acquired":true,"shares":4600,"price":1.01,"value":4646.0,"ownership":{"direct":true},"balance_after":214759,"source":{"system":"sec-edgar","filing":"0001104659-21-093671","document":"tm2122438-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921093671/tm2122438-2_4seq1.xml","form_type":"4"}},{"id":2629939,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-07-20T01:02:01.000Z","date":"2021-01-19","kind":"exercise","acquired":false,"shares":5727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof."}],"balance_after":73203,"derivative":{"exercise_price":1.01,"expiration_date":"2025-11-01","underlying":"Common Stock","underlying_shares":5727},"source":{"system":"sec-edgar","filing":"0001104659-21-093670","document":"tm2122438-3_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921093670/tm2122438-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-01-19"}},{"id":2629938,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-07-20T01:02:01.000Z","date":"2021-01-15","kind":"exercise","acquired":false,"shares":29273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof."}],"balance_after":78930,"derivative":{"exercise_price":1.01,"expiration_date":"2025-11-01","underlying":"Common Stock","underlying_shares":29273},"source":{"system":"sec-edgar","filing":"0001104659-21-093670","document":"tm2122438-3_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921093670/tm2122438-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-01-19"}},{"id":2629937,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-07-20T01:02:01.000Z","date":"2021-01-14","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof."}],"balance_after":108203,"derivative":{"exercise_price":1.01,"expiration_date":"2025-11-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-21-093670","document":"tm2122438-3_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921093670/tm2122438-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-01-19"}},{"id":2629936,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-07-20T01:02:01.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":5127,"price":42.38,"value":217282.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.76. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 175,994 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 458,852 shares of the Issuer's common stock, 284,936 of which are exercisable as of the date hereof. The original Form 4 filed on January 19, 2021 is being amended by this Form 4 solely to correct an administrative error, which misreported the total number of options held by the reporting person and the amount exercisable as of January 19, 2021."}],"balance_after":175994,"source":{"system":"sec-edgar","filing":"0001104659-21-093670","document":"tm2122438-3_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921093670/tm2122438-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-01-19"}},{"id":2629935,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-07-20T01:02:01.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":600,"price":43.24,"value":25944.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.88 to $43.86. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":181121,"source":{"system":"sec-edgar","filing":"0001104659-21-093670","document":"tm2122438-3_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921093670/tm2122438-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-01-19"}},{"id":2629934,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-07-20T01:02:01.000Z","date":"2021-01-19","kind":"exercise","acquired":true,"shares":5727,"price":1.01,"value":5784.27,"ownership":{"direct":true},"balance_after":181721,"source":{"system":"sec-edgar","filing":"0001104659-21-093670","document":"tm2122438-3_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921093670/tm2122438-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-01-19"}},{"id":2629933,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-07-20T01:02:01.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":29273,"price":43.58,"value":1275717.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."}],"balance_after":175994,"source":{"system":"sec-edgar","filing":"0001104659-21-093670","document":"tm2122438-3_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921093670/tm2122438-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-01-19"}},{"id":2629932,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-07-20T01:02:01.000Z","date":"2021-01-15","kind":"exercise","acquired":true,"shares":29273,"price":1.01,"value":29565.73,"ownership":{"direct":true},"balance_after":205267,"source":{"system":"sec-edgar","filing":"0001104659-21-093670","document":"tm2122438-3_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921093670/tm2122438-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-01-19"}},{"id":2629931,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-07-20T01:02:01.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":20000,"price":45.02,"value":900400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."}],"balance_after":175994,"source":{"system":"sec-edgar","filing":"0001104659-21-093670","document":"tm2122438-3_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921093670/tm2122438-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-01-19"}},{"id":2629930,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-07-20T01:02:01.000Z","date":"2021-01-14","kind":"exercise","acquired":true,"shares":20000,"price":1.01,"value":20200.0,"ownership":{"direct":true},"balance_after":195994,"source":{"system":"sec-edgar","filing":"0001104659-21-093670","document":"tm2122438-3_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921093670/tm2122438-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-01-19"}},{"id":2664101,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":35406,"kind":"person","name":"Esposito Pamela","position":1,"cik":"0001744425","reported_name":"Esposito Pamela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T20:50:24.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":20063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 16, 2022 and (ii) the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":20063,"derivative":{"exercise_price":49.1,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":20063},"source":{"system":"sec-edgar","filing":"0000899243-21-024447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000089924321024447/doc4.xml","form_type":"4"}}],"next_cursor":"2021-06-17T20:50:24.000000Z,2664101"}